{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:35:14Z","timestamp":1791812114238,"version":"4.3.4"},"reference-count":133,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jtct.2024.05.020","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T02:07:06Z","timestamp":1728094026000},"page":"S513-S533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"S","title":["Cutaneous Chronic Graft-Versus-Host Disease: Clinical Manifestations, Diagnosis, Management, and Supportive Care"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9166-1549","authenticated-orcid":false,"given":"Connie R.","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6494-9598","authenticated-orcid":false,"given":"Alana L.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7638-7537","authenticated-orcid":false,"given":"Manjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8363-2438","authenticated-orcid":false,"given":"David","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9978-3071","authenticated-orcid":false,"given":"Jean","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K.","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7929-1450","authenticated-orcid":false,"given":"Nada","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-4324","authenticated-orcid":false,"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-0011","authenticated-orcid":false,"given":"Benjamin H.","family":"Kaffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0396-2005","authenticated-orcid":false,"given":"Emily","family":"Baumrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jtct.2024.05.020_bib0001","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","article-title":"Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials","volume":"23","year":"2005","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"7","key":"10.1016\/j.jtct.2024.05.020_bib0002","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IIa. The 2020 clinical implementation and early diagnosis working group report","volume":"27","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0003","doi-asserted-by":"crossref","first-page":"504.e1","DOI":"10.1016\/j.jtct.2020.12.027","article-title":"Epidemiology and treatment of chronic graft-versus-host disease post-allogeneic hematopoietic cell transplantation: a US claims analysis","volume":"27","author":"Bachier","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0004","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2002-01-0011","article-title":"Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial","volume":"100","author":"Flowers","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/jamadermatol.2022.6624","article-title":"Prognostic value of cutaneous disease severity estimates on survival outcomes in patients with chronic graft-vs-host disease","volume":"159","author":"Baumrin","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0006","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bbmt.2017.06.011","article-title":"Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease","volume":"23","author":"Kurosawa","year":"2017","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"13","key":"10.1016\/j.jtct.2024.05.020_bib0007","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1182\/blood-2012-04-424135","article-title":"Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium","volume":"120","author":"Jacobsohn","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2024.05.020_bib0008","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/bmt.2014.188","article-title":"NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD","volume":"49","author":"Curtis","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2024.05.020_bib0009","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bbmt.2013.05.006","article-title":"Cutaneous complications in hematopoietic cell transplant recipients: impact of biopsy on patient management","volume":"19","author":"Paun","year":"2013","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jtct.2024.05.020_bib0010","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","article-title":"Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.jtct.2024.05.020_bib0011","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2024.05.020_bib0012","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jtct.2021.03.029","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IIb. The 2020 preemptive therapy working group report","volume":"27","author":"Pidala","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"5-6","key":"10.1016\/j.jtct.2024.05.020_bib0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/phpp.12273","article-title":"Photo-induced graft-versus-host disease","volume":"32","author":"Hardy","year":"2016","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"26","key":"10.1016\/j.jtct.2024.05.020_bib0014","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0015","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/bjd.13894","article-title":"Chronic cutaneous lichenoid graft-versus-host disease at the area of herpes zoster infection and at a vaccination site","volume":"173","author":"Palacios-Alvarez","year":"2015","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0016","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF02983564","article-title":"Chronic graft-versus-host disease following varicella-zoster virus infection in allogeneic stem cell transplant recipients","volume":"78","author":"Kawano","year":"2003","journal-title":"Int J Hematol"},{"issue":"7","key":"10.1016\/j.jtct.2024.05.020_bib0017","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-4362.2003.01723_2.x","article-title":"Dermatomal lichenoid graft-versus-host disease within herpes zoster scars","volume":"42","author":"Sanli","year":"2003","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0018","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0019","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount Sinai acute GVHD international consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ijd.15186","article-title":"A clinical and histological comparison between acute cutaneous graft-versus-host disease and other maculopapular eruptions following hematopoietic stem cell transplantation: a retrospective cohort","volume":"60","author":"Chanprapaph","year":"2021","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0021","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaad.2010.07.042","article-title":"Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions","volume":"65","author":"Byun","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jtct.2024.05.020_bib0022","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/jdv.12737","article-title":"Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease","volume":"29","author":"Hillen","year":"2015","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0023","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2016-07-686642","article-title":"Classification systems for chronic graft-versus-host disease","volume":"129","author":"Lee","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0024","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.bbmt.2007.07.001","article-title":"Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria","volume":"13","author":"Jagasia","year":"2007","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3324\/haematol.2011.055186","article-title":"Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a chronic graft-versus-host disease consortium study","volume":"97","author":"Pidala","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jtct.2024.05.020_bib0026","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/leu.2012.292","article-title":"Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study","volume":"27","author":"Arora","year":"2013","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0027","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbmt.2008.07.015","article-title":"Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy","volume":"14","author":"P\u00e9rez-Sim\u00f3n","year":"2008","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0028","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jtct.2021.06.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 highly morbid forms report","volume":"27","author":"Wolff","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"10.1016\/j.jtct.2024.05.020_bib0029","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamadermatol.2019.4857","article-title":"Quality of life in patients with skin of color and chronic graft-vs-host disease","volume":"156","author":"Smith","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0030","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0031","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2015-08-662874","article-title":"Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease","volume":"127","author":"Palmer","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2024.05.020_bib0032","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaad.2019.03.031","article-title":"Histologic and clinical cross-sectional study of chronic hair loss in patients with cutaneous chronic graft-versus-host disease","volume":"81","author":"Marks","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0033","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-4632.2004.01629.x","article-title":"Evaluation of nail involvement in patients with chronic cutaneous graft versus host disease: a single-center study from Turkey","volume":"43","author":"Sanli","year":"2004","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0034","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41409-018-0309-z","article-title":"Longstanding alopecia and nail dystrophy are associated with more severe overall chronic graft-versus-host disease in adults","volume":"54","author":"Naftulin","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamadermatol.2014.1550","article-title":"Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease","volume":"151","author":"Zuo","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.jtct.2024.05.020_bib0036","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jamadermatol.2018.2927","article-title":"Alopecia universalis and chronic graft-vs-host disease treated with ruxolitinib","volume":"154","author":"Borg","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0037","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3325\/cmj.2016.57.229","article-title":"High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease","volume":"57","author":"\u010ceovi\u0107","year":"2016","journal-title":"Croat Med J"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0038","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/DAD.0b013e31823395f0","article-title":"Chronic cutaneous graft-versus-host disease simulating hypertrophic lupus erythematosus\u2014a case report of a new morphologic variant of graft-versus-host disease","volume":"34","author":"Hu","year":"2012","journal-title":"Am J Dermatopathol"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0039","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2230.2005.01934.x","article-title":"Chronic graft-versus-host disease with skin signs suggestive of dermatomyositis","volume":"31","author":"Arin","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.23885","article-title":"Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria","volume":"90","author":"Kuzmina","year":"2015","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0041","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaad.2005.06.015","article-title":"Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum","volume":"53","author":"Schaffer","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0042","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood-2011-04-314815","article-title":"How I conduct a comprehensive chronic graft-versus-host disease assessment","volume":"118","author":"Carpenter","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2024.05.020_bib0043","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bmt.1705487","article-title":"Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management","volume":"38","author":"Zantomio","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0044","first-page":"1163","article-title":"Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation","volume":"88","author":"Spinelli","year":"2003","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0045","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.V74.4.1428.1428","article-title":"Predictors of death from chronic graft-versus-host disease after bone marrow transplantation","volume":"74","author":"Wingard","year":"1989","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2024.05.020_bib0046","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0047","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2024.05.020_bib0048","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.bbmt.2007.06.002","article-title":"Grover's disease after bone marrow transplantation","volume":"13","author":"Bola\u00f1os-Meade","year":"2007","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0049","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbmt.2008.12.491","article-title":"Voriconazole-induced phototoxicity masquerading as chronic graft-versus-host disease of the skin in allogeneic hematopoietic cell transplant recipients","volume":"15","author":"Patel","year":"2009","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.05.020_bib0050","series-title":"Pathology of hematopoietic cell transplantation. Thomas\u2019 Hematopoietic Cell Transplantation","first-page":"286","author":"Sale","year":"2003"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0051","first-page":"367","article-title":"Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors","volume":"6","author":"Lerner","year":"1974","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0052","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaad.2004.02.011","article-title":"Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life","volume":"51","author":"Ziemer","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtct.2024.05.020_bib0053","series-title":"Graft-Versus-Host Disease: Immunology, Pathophysiology, and Treatment","first-page":"587","article-title":"Pathology of chronic GVHD","author":"Shulman","year":"1990"},{"key":"10.1016\/j.jtct.2024.05.020_bib0054","series-title":"Graft-vs-Host Disease","first-page":"229","article-title":"Pathology and pathogenesis of cutaneous graft-vs.-host disease","author":"Wagner","year":"2004"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/1523-1747.ep12392774","article-title":"Reappraisal of histologic features of the acute cutaneous graft-versus-host reaction based on an allogeneic rodent model","volume":"103","author":"Horn","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0056","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.jtct.2024.05.020_bib0057","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archdermatol.2009.78","article-title":"Magnetic resonance imaging in sclerotic-type chronic graft-vs-host disease","volume":"145","author":"Clark","year":"2009","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1016\/j.jtct.2024.05.020_bib0058","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/bmt.2015.191","article-title":"Identification and validation of biomarkers associated with acute and chronic graft versus host disease","volume":"50","author":"Ahmed","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0059","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2169\/internalmedicine.56.7329","article-title":"Chronic graft-versus-host disease presenting with multiple punctate intracranial lesions on contrast-enhanced magnetic resonance imaging","volume":"56","author":"Terada","year":"2017","journal-title":"Intern Med Tokyo Jpn"},{"issue":"9","key":"10.1016\/j.jtct.2024.05.020_bib0060","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jtct.2021.05.030","article-title":"Methods to assess disease activity and severity in cutaneous chronic graft-versus-host disease: a critical literature review","volume":"27","author":"Shakshouk","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2024.05.020_bib0061","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/bbmt.2002.v8.pm12234170","article-title":"Development and validation of a scale to measure symptoms of chronic graft-versus-host disease","volume":"8","author":"Lee","year":"2002","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0062","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"9","key":"10.1016\/j.jtct.2024.05.020_bib0063","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bbmt.2019.05.016","article-title":"Resolved versus active chronic graft-versus-host disease: impact on post-transplantation quality of life","volume":"25","author":"Kurosawa","year":"2019","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.05.020_bib0064","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221113789","article-title":"Results of multicenter phase ii study with imatinib mesylate in allogeneic recipients with steroid-refractory chronic GVHD","volume":"31","author":"Baek","year":"2022","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jtct.2024.05.020_bib0065","doi-asserted-by":"crossref","first-page":"e1323","DOI":"10.1111\/jdv.19311","article-title":"Dupilumab for refractory sclerotic-type cutaneous graft-versus-host disease","volume":"37","author":"Mital","year":"2023","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0066","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3324\/haematol.2014.109611","article-title":"Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease","volume":"99","author":"Inamoto","year":"2014","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.jtct.2024.05.020_bib0067","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbmt.2011.04.002","article-title":"A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change","volume":"17","author":"Mitchell","year":"2011","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0068","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0069","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbmt.2005.10.023","article-title":"Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology Working Group Report","volume":"12","author":"Shulman","year":"2006","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0070","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1111\/bjh.18141","article-title":"Artificial intelligence recognition of cutaneous chronic graft-versus-host disease by a deep learning neural network","volume":"197","author":"McNeil","year":"2022","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0071","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2991\/chi.k.210704.001","article-title":"Baseline photos and confident annotation improve automated detection of cutaneous graft-versus-host disease","volume":"3","author":"Liu","year":"2021","journal-title":"Clin Hematol Int"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0072","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10278-022-00730-8","article-title":"Non-expert markings of active chronic graft-versus-host disease photographs: optimal metrics of training effects","volume":"36","author":"Parks","year":"2023","journal-title":"J Digit Imaging"},{"issue":"7","key":"10.1016\/j.jtct.2024.05.020_bib0073","doi-asserted-by":"crossref","DOI":"10.1002\/jbio.202300009","article-title":"Hyperspectral imaging to accurately segment skin erythema and hyperpigmentation in cutaneous chronic graft-versus-host disease","volume":"16","author":"Saknite","year":"2023","journal-title":"J Biophotonics"},{"issue":"9","key":"10.1016\/j.jtct.2024.05.020_bib0074","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archderm.137.9.1202","article-title":"Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients","volume":"137","author":"Choi","year":"2001","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.jtct.2024.05.020_bib0075","first-page":"665","article-title":"Topical tacrolimus\u2014a novel treatment alternative for cutaneous chronic graft-versus-host disease","volume":"16","author":"Elad","year":"2003","journal-title":"Transpl Int: Off J Eur Soc Organ Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0076","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1002\/phar.1418","article-title":"Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease","volume":"34","author":"Olson","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jtct.2024.05.020_bib0077","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jdcr.2023.03.023","article-title":"Cutaneous graft-versus-host disease within chronic photodamaged skin: a case series demonstrating role for topical 5-fluorouracil","volume":"36","author":"Gray","year":"2023","journal-title":"JAAD Case Rep"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2024.05.020_bib0078","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood-2021-144743","volume":"138","author":"Markova","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0079","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2133.2009.09503.x","article-title":"Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients","volume":"162","author":"Brazzelli","year":"2010","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jtct.2024.05.020_bib0080","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.bmt.1701460","article-title":"Chronic graft-versus-host disease treated with UVB phototherapy","volume":"22","author":"Enk","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0081","first-page":"1061","article-title":"Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA)","volume":"17","author":"Vogelsang","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"1 Pt 1","key":"10.1016\/j.jtct.2024.05.020_bib0082","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0190-9622(85)70005-9","article-title":"Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction","volume":"12","author":"Hymes","year":"1985","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0083","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0781.2002.00719.x","article-title":"Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease","volume":"18","author":"Leiter","year":"2002","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0084","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2230.2000.00589.x","article-title":"A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis","volume":"25","author":"Cooper","year":"2000","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0085","first-page":"667","article-title":"PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease","volume":"18","author":"Ghoreschi","year":"2008","journal-title":"Eur J Dermatol EJD"},{"issue":"5","key":"10.1016\/j.jtct.2024.05.020_bib0086","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.clindermatol.2016.05.012","article-title":"Phototherapy for sclerosing skin conditions","volume":"34","author":"Teske","year":"2016","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0087","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1468-3083.2003.00516.x","article-title":"Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonography","volume":"17","author":"Gottl\u00f6ber","year":"2003","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"issue":"1 Pt 1","key":"10.1016\/j.jtct.2024.05.020_bib0088","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0190-9622(00)90023-9","article-title":"Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy","volume":"42","author":"Grundmann-Kollmann","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jtct.2024.05.020_bib0089","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1067\/mjd.2002.121352","article-title":"UVA1 therapy for sclerodermic graft-versus-host disease of the skin","volume":"46","author":"St\u00e4nder","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0090","first-page":"1169","article-title":"Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease","volume":"88","author":"Calzavara Pinton","year":"2003","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jtct.2024.05.020_bib0091","doi-asserted-by":"crossref","first-page":"599","DOI":"10.6004\/jnccn.2020.0021","article-title":"Hematopoietic cell transplantation, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Saad","year":"2020","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"21","key":"10.1016\/j.jtct.2024.05.020_bib0092","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0093","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2024.05.020_bib0094","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954268","article-title":"Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: a meta-analysis","volume":"13","author":"Fan","year":"2022","journal-title":"Front Immunol"},{"issue":"22","key":"10.1016\/j.jtct.2024.05.020_bib0095","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2024.05.020_bib0096","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/1078-0432.CCR-21-4176","article-title":"FDA approval summary: belumosudil for adult and pediatric patients 12 years and older with chronic GvHD after two or more prior lines of systemic therapy","volume":"28","author":"Przepiorka","year":"2022","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"9","key":"10.1016\/j.jtct.2024.05.020_bib0097","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jtct.2023.07.001","article-title":"Extracorporeal photopheresis in graft-versus-host disease","volume":"29","author":"Asensi Cant\u00f3","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2024.05.020_bib0098","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2008-03-141481","article-title":"A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease","volume":"112","author":"Flowers","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0099","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood-2002-11-3351","article-title":"Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response","volume":"102","author":"Seaton","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2024.05.020_bib0100","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2005-09-3907","article-title":"Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD","volume":"107","author":"Couriel","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0101","first-page":"193","article-title":"Treatment of chronic GVHD with extracorporeal photochemotherapy","volume":"48","author":"Bojanic","year":"2013","journal-title":"Transfus Apher Sci: Off J World Apher Assoc: Off J Eur Soc Haemapheresis"},{"key":"10.1016\/j.jtct.2024.05.020_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107387","article-title":"Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure","volume":"134","author":"Linn","year":"2023","journal-title":"Leuk Res"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0103","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.22.00958","article-title":"Axatilimab for chronic graft-versus-host disease after failure of at least two prior systemic therapies: results of a phase I\/II study","volume":"41","author":"Kitko","year":"2023","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"9","key":"10.1016\/j.jtct.2024.05.020_bib0104","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2009.04.003","article-title":"Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis","volume":"15","author":"Kharfan-Dabaja","year":"2009","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12185-009-0370-x","article-title":"Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease","volume":"90","author":"Teshima","year":"2009","journal-title":"Int J Hematol"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0106","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ijd.14027","article-title":"Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab","volume":"58","author":"Huff","year":"2019","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0107","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood-2009-02-204750","article-title":"Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease","volume":"114","author":"Magro","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0108","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbmt.2015.03.006","article-title":"Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease","volume":"21","author":"Baird","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jtct.2024.05.020_bib0109","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1182\/blood-2012-09-453928","article-title":"Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD","volume":"120","author":"de Masson","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1158\/1078-0432.CCR-15-1443","article-title":"A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation","volume":"22","author":"Arai","year":"2016","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0111","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamadermatol.2015.3902","article-title":"Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study","volume":"152","author":"Omland","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.jtct.2024.05.020_bib0112","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamadermatol.2015.121","article-title":"Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review","volume":"151","author":"DePry","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0113","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaad.2021.10.004","article-title":"A 10-year retrospective cohort study of ruxolitinib and association with nonmelanoma skin cancer in patients with polycythemia vera and myelofibrosis","volume":"86","author":"Lin","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jtct.2024.05.020_bib0114","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bmt.2015.63","article-title":"Secondary solid cancer screening following hematopoietic cell transplantation","volume":"50","author":"Inamoto","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.7861\/clinmedicine.16-1-62","article-title":"Non-melanoma skin cancer","volume":"16","author":"Griffin","year":"2016","journal-title":"Clin Med"},{"issue":"14","key":"10.1016\/j.jtct.2024.05.020_bib0116","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1200\/JCO.2011.39.3652","article-title":"Use of tanning beds and incidence of skin cancer","volume":"30","author":"Zhang","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jtct.2024.05.020_bib0117","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/aje\/kwv282","article-title":"History of severe sunburn and risk of skin cancer among women and men in 2 prospective cohort studies","volume":"183","author":"Wu","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0118","first-page":"28","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"14","key":"10.1016\/j.jtct.2024.05.020_bib0119","first-page":"2040","article-title":"Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"6","key":"10.1016\/j.jtct.2024.05.020_bib0120","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/pde.13984","article-title":"Sun exposure and protection practices in children after allogeneic hematopoietic stem cell transplantation: a survey-based cross-sectional cohort study","volume":"36","author":"Li","year":"2019","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"10.1016\/j.jtct.2024.05.020_bib0121","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jamadermatol.2020.1141","article-title":"Voriconazole and the risk of keratinocyte carcinomas among lung transplant recipients in the United States","volume":"156","author":"D'Arcy","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jtct.2024.05.020_bib0122","unstructured":"VFEND\u00ae Warnings and Precautions (voriconazole) | Pfizer Medical Information \u2013 US. Accessed October 4, 2023. https:\/\/www.pfizermedicalinformation.com\/en-us\/vfend\/warnings"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0123","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038567","article-title":"Skin and wound care for individuals with graft versus host disease: a scoping review protocol","volume":"10","author":"Campbell","year":"2020","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0124","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1702756","article-title":"Severe cutaneous ulceration following treatment with thalidomide for GVHD","volume":"27","author":"Schlossberg","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.05.020_bib0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jaad.2022.12.023","article-title":"Chronic graft-versus-host disease. Part II: disease activity grading and therapeutic management","volume":"90","author":"Baumrin","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0126","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2014.05.034","article-title":"Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity","volume":"71","author":"Kaffenberger","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jtct.2024.05.020_bib0127","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2133.2005.07036.x","article-title":"Eruptive angiomas associated with graft-versus-host disease","volume":"154","author":"Soo","year":"2006","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0128","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2133.2003.05504.x","article-title":"Eruptive angiomatous lesions associated with graft-versus-host disease","volume":"149","author":"Adamski","year":"2003","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jtct.2024.05.020_bib0129","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.bbmt.2006.08.043","article-title":"Cutaneous manifestations of chronic graft-versus-host disease","volume":"12","author":"Hymes","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2024.05.020_bib0130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaad.2017.01.036","article-title":"Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention","volume":"77","author":"Chaowattanapanit","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.jtct.2024.05.020_bib0131","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bmt.1704272","article-title":"CO2 laser in oral graft-versus-host disease: a pilot study","volume":"32","author":"Elad","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2024.05.020_bib0132","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/14764172.2019.1710537","article-title":"Fractional CO2 laser for the treatment of sclerodermatous cGVHD","volume":"22","author":"Labadie","year":"2020","journal-title":"J Cosmet Laser Ther: Off Publ Eur Soc Laser Dermatol"},{"issue":"3","key":"10.1016\/j.jtct.2024.05.020_bib0133","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5535\/arm.2019.43.3.347","article-title":"Rehabilitation in children with sclerodermoid chronic graft-versus-host disease: case series","volume":"43","author":"Jung","year":"2019","journal-title":"Ann Rehabil Med"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724004329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724004329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T01:51:35Z","timestamp":1729648295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724004329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":133,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2666636724004329"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.05.020","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous Chronic Graft-Versus-Host Disease: Clinical Manifestations, Diagnosis, Management, and Supportive Care","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}